DEL PRATO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 63.113
AS - Asia 28.375
EU - Europa 23.538
SA - Sud America 4.221
AF - Africa 749
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 29
Totale 120.075
Nazione #
US - Stati Uniti d'America 56.706
CN - Cina 8.235
SG - Singapore 8.079
IT - Italia 6.243
CA - Canada 6.102
HK - Hong Kong 5.332
PL - Polonia 3.893
BR - Brasile 3.536
SE - Svezia 2.720
VN - Vietnam 2.169
BG - Bulgaria 2.030
DE - Germania 1.704
UA - Ucraina 1.430
KR - Corea 1.243
GB - Regno Unito 1.123
TR - Turchia 1.038
FR - Francia 1.034
RU - Federazione Russa 1.000
FI - Finlandia 901
CH - Svizzera 656
IN - India 458
JP - Giappone 423
BD - Bangladesh 254
AT - Austria 237
AR - Argentina 214
IQ - Iraq 201
CI - Costa d'Avorio 149
MX - Messico 136
ID - Indonesia 127
EC - Ecuador 122
SA - Arabia Saudita 120
NL - Olanda 118
ZA - Sudafrica 118
PK - Pakistan 100
BE - Belgio 92
SN - Senegal 92
MA - Marocco 85
VE - Venezuela 84
UZ - Uzbekistan 78
ES - Italia 73
CO - Colombia 72
IR - Iran 57
IE - Irlanda 54
EG - Egitto 53
IL - Israele 50
PY - Paraguay 50
NG - Nigeria 46
MY - Malesia 44
UY - Uruguay 44
JO - Giordania 42
PH - Filippine 40
CL - Cile 39
KE - Kenya 39
AU - Australia 38
PE - Perù 37
NP - Nepal 33
DZ - Algeria 32
JM - Giamaica 31
LT - Lituania 30
TN - Tunisia 30
BJ - Benin 26
CZ - Repubblica Ceca 24
EU - Europa 23
TW - Taiwan 23
GR - Grecia 22
KZ - Kazakistan 22
AE - Emirati Arabi Uniti 21
AZ - Azerbaigian 21
OM - Oman 21
PS - Palestinian Territory 21
PT - Portogallo 21
PA - Panama 19
NO - Norvegia 18
DO - Repubblica Dominicana 17
RO - Romania 17
KG - Kirghizistan 16
TT - Trinidad e Tobago 16
BB - Barbados 15
BO - Bolivia 14
LB - Libano 14
AL - Albania 12
CR - Costa Rica 12
DK - Danimarca 12
GE - Georgia 12
BY - Bielorussia 11
HN - Honduras 11
HU - Ungheria 11
RS - Serbia 11
ET - Etiopia 10
GT - Guatemala 10
NZ - Nuova Zelanda 10
SY - Repubblica araba siriana 10
TH - Thailandia 10
NI - Nicaragua 9
QA - Qatar 9
SV - El Salvador 9
AM - Armenia 8
BH - Bahrain 8
HR - Croazia 8
AO - Angola 7
Totale 119.907
Città #
Woodbridge 6.656
Ashburn 5.381
Hong Kong 5.280
Ann Arbor 5.212
Montreal 4.636
Singapore 4.540
Fairfield 4.434
Houston 4.408
Chandler 2.852
San Jose 2.547
Dallas 2.358
Milan 2.349
Sofia 2.015
Jacksonville 2.000
Seattle 1.828
Wilmington 1.601
Shanghai 1.591
Santa Clara 1.572
Cambridge 1.502
Beijing 1.476
Hefei 1.310
Ottawa 1.268
New York 1.234
Seoul 1.215
Boardman 927
Princeton 917
Lawrence 782
Nanjing 717
Lauterbourg 677
Medford 675
Bern 628
Los Angeles 589
Izmir 587
Serra 525
Ho Chi Minh City 501
Des Moines 483
Tokyo 390
Hanoi 374
Jüchen 350
Dearborn 345
Council Bluffs 338
Istanbul 335
Buffalo 296
Nanchang 292
San Diego 290
Rome 270
Dong Ket 254
Boulder 253
Redondo Beach 245
São Paulo 241
The Dalles 206
Columbus 186
London 186
Chicago 177
Vienna 172
Redwood City 171
Frankfurt am Main 170
Kunming 169
Shenyang 156
Florence 151
Abidjan 148
Pisa 143
Changsha 139
Falls Church 138
Bremen 134
Munich 132
Helsinki 123
Rio de Janeiro 122
Ogden 116
Hebei 113
Tianjin 101
Jiaxing 98
Dakar 91
Lancaster 90
Orem 90
Brussels 89
Baghdad 88
Nuremberg 88
Washington 86
Grafing 84
Belo Horizonte 80
Düsseldorf 80
San Francisco 80
Warsaw 78
Guangzhou 76
Haiphong 76
Norwalk 75
Brasília 70
Tashkent 70
Curitiba 65
Hangzhou 63
Chennai 62
Fuzhou 62
Turku 60
Da Nang 59
Dhaka 59
Manchester 59
Jinan 58
Orange 57
Verona 57
Totale 86.849
Nome #
RISULTATI AD UN ANNO NEL TRAPIANTO SIMULTANEO DI PANCREAS-RENE: LA SCELTA PREEMPTIVE E’ VANTAGGIOSA? 4.501
ACE-INHIBITION PROTECTS PANCREATIC HUMAN ISLETS FROM GLUCOTOXICITY AND IMPROVES THE FUNCTION OF ISLETS FROM TYPE 2 DIABETIC PATIENTS 4.146
UN INSOLITO CASO DI IPOGLICEMIA IPERINSULINEMICA DA NESIDIOBLASTOSI E INSULINOMA 807
Q192R PARAOXONASE(PON)1 POLYMORPHISM, INSULIN SENSITIVITY AND ENDOTHELIAL FUNCTION IN ESSENTIAL HYPERTENSIVE MEN 291
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 288
Type 2 diabetes albuminuric and non-albuminuric phenotypes have different morphological and functional ultrasound features of diabetic kidney disease 284
G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: The role of type 2 diabetes and fatty acids 281
Altered Visual Plasticity in Morbidly Obese Subjects 271
Gestational diabetes, inflammation, and late vascular disease 267
G-protein-coupled receptor 40 (GPR40) expression in human pancreatic 256
Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes 251
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus 249
Activation of the hexosamine pathway leads to phosphorylation of IRS-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mTOR insulin biosynthetic pathway in RIN pancreatic {beta}-cells 248
Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes 246
Alpha-Adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria JOURNAL OF HYPERTENSION JUN 2006 VL 24 IS 6 BP 1217 EP 1217 242
Insulin resistance in Cushing's syndrome. 238
The antiketogenic effect of alanine in normal man: evidence for an alanine-ketone body cycle. 231
Absence of islet alpha cell function in pancreatectomized patients. 231
Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats. 228
Body composition study in the elderly: comparison between tritium dilution method and dual photon absorptiometry 227
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. 227
Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects. 224
Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients 223
The contribution of hyperglycaemia and hypoinsulinaemia to the insulin resistance of streptozotocin-diabetic rats 222
Management of thyrotoxicosis induced by PD1 or PD-L1 blockade 222
Metabolic control during total parenteral nutrition: use of an artificial endocrine pancreas. 220
Prevalence and risk factors for gestational diabetes assessed by universal screening 220
Brain effect of bariatric surgery in people with obesity 219
Effects of bariatric surgery on brain glucose metabolism and cognitive function: insight from dynamic FDG PET/CT study 216
Effect of diabetes on hospitalization for ischemic stroke and related in-hospital mortality. A study in Tuscany, Italy, over years 2004-2011 215
Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy. 214
Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy 214
Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients 214
Long-Term (5 Years) Efficacy and Safety of Pancreas Transplantation Alone in Type 1 Diabetic Patients 212
Selective screening for GDM in Italy: application and effectiveness of National Guidelines 211
Dissociation of the effects of epinephrine and insulin on glucose and protein metabolism. 211
Exenatide modulates visual cortex responses 211
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. 208
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 208
Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor. 207
Functional and survival analysis of isolated human islets 206
The presence of retinopathy in patients with secondary diabetes following pancreatectomy or chronic pancreatitis. 205
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes. 204
ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations. 204
The effects of bariatric surgery on the brain glucose metabolism and its biological mediators: an insight from dynamic 18F-FDG PET/CT study 204
The relationship between alanine and ketone body in vivo 203
Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality 203
1-Hour OGTT Plasma Glucose as a Marker of Progressive Deterioration of Insulin Secretion and Action in Pregnant Women. 203
A SINGLE CENTER, OPEN, PROSPECTIVE, RANDOMIZED COMPARISON OF CYCLOSPORINE VERSUS TACROLIMUS IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION 202
ROLE OF G-PROTEIN-COUPLED RECEPTOR 40 (GPR40) IN NON-DIABETIC AND TYPE 2 DIABETIC PANCREATIC ISLETS. 199
A Common Polymorphism in the Promoter of UCP2 Contributes to the Variation in Insulin Secretion in Glucose-Tolerant Subjects 199
Glucagon-like peptide-1 (GLP-1) secretion in women with gestational diabetes mellitus during and after pregnancy 199
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo 199
Retrospective analysis of daily glucose profile in type 1 diabetic patients with continuous subcutaneous insulin infusion (CSII) 198
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4 198
The vascular effects of doxazosin in hypertension complicated by metabolic syndrome 198
What therapy do our NIDDM patients need? Insulin releasers 197
Simultaneous pancreas-kidney transplantation is improved by living kidney donation program 197
Optimizing management of metabolic syndrome to reduce the risk: focus on life-style 197
Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents 196
Insulin receptors on circulating blood cells from patients with pancreatogenic diabetes: a comparison with type I diabetes and normal subjects. 196
Pancreas transplant alone (PTA) in type 1 diabetic patients (T1DM): A 3-yr metabolic and diabetic complications follow-up 196
ACE gene insertion/deletion polymorphism modulates capillary permeability in hypertension 196
Circulating Endothelial Cells (EPC) and Endothelium-derived Microparticles (EdMPs) time-course throughout the natural history of type 2 diabetes 196
Beta- and alpha-cell dysfunction in type 2 diabetes 195
Basal insulin and cardiovascular and other outcomes in dysglycemia. 195
A Fermented Whole Grain Prevents Lipopolysaccharides-Induced Dysfunction in Human Endothelial Progenitor Cells 195
SINGLE CENTER, OPEN, PROSPECTIVE, RANDOMIZED, PILOT STUDY COMPARING CYCLOSPORINE VERSUS TACROLIMUS IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION 194
Hyperglucagonemia and insulin-mediated glucose metabolism 193
An off-the-shelf instant contact casting device for the management of diabetic foot ulcers - A randomized prospective trial versus traditional fiberglass cast 193
Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management 193
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. 193
Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid intima-media thickening. 192
Reconstructing the rate of appearance of subcutaneous insulin by deconvolution. 191
Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion 191
The beneficial effects of pancreas transplant alone on diabetic nephropathy 191
Gliclazide protects isolated human islets from apoptosis induced by intermittent high glucose: the role of oxidative stress 191
Optimal therapy of type 2 diabetes: a controversial challenge 191
Insulin secretion and action affect glucose variability in the early stages of glucose intolerance 190
PANCREAS TRANSPLANTATION: EFFECTS ON DIABETIC RETINOPATHY 190
Successful solitary pancreas transplantation with portal-enteric drainage following unsuccessful islet cell transplantation 190
Epigenetic regulation of PGC-1 alpha inhuman type 2 diabetic islets and effect on insulin secretion 190
Serum gamma-glutamyltransferase levels are related to insulin sensitivity and secretion in subjects with abnormal glucose regulation 190
Grain and bean lysates improve function of endothelial progenitor cells from human peripheral blood: involvement of the endogenous antioxidant defenses. 190
Early vs. standard screening and treatment of gestational diabetes in high-risk women – An attempt to determine relative advantages and disadvantages 190
Portal enteric-drained solitary pancreas transplantation without surveillance biopsy: is it safe? 188
Type 2 diabetes mellitus: focus on new treatments and special populations 187
A call to action - the UN Resolution on diabetes 187
Is maternal educational level a risk factor for gestational diabetes in Caucasian women? 187
Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin 187
Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Reply to Rigalleau V, Blanco L, Alexandre L et al [letter] 187
Oxidative stress in isolated human pancreatic islets: possible role of frataxin 186
Glucose transporter 2 gene polymorphisms and beta-cell function in isolated human pancreatic islets 185
Role of tissue specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle 184
A common polymorphism in the ccl2 gene regulatory region affects mcp-1 gene expression and function of isolated non-diabetic and type 2 diabetic islets 184
Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid Metabolic Syndrome 184
Diabetes programme facts and figures 183
Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: comparison with regular insulin 183
Pre-pregnancy obesity, gestational diabetes or gestational weight gain: Which is the strongest predictor of pregnancy outcomes? 183
Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus 182
Totale 29.701
Categoria #
all - tutte 325.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 325.965


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.379 241 610 186 543 1.596 1.183 213 441 297 302 462 2.305
2022/20237.982 1.152 730 381 800 1.086 1.161 86 685 1.253 84 470 94
2023/202416.714 1.376 1.129 1.122 568 1.230 1.295 172 192 162 8.525 151 792
2024/202521.686 131 916 274 1.145 1.266 1.718 2.029 1.615 2.205 3.211 2.681 4.495
2025/202623.599 1.601 3.404 3.248 2.175 1.939 2.345 3.253 1.108 1.133 2.248 701 444
2026/2027135 135 0 0 0 0 0 0 0 0 0 0 0
Totale 120.956